Table 3.

Improvement in dental infection complications in all three antibiotic groups

Parameter	Cephalexin CV N = 87			Cefuroxime N = 94			Co-amoxiclav N = 174			p-Value (cephalexin CV vs cefuroxime)	p-Value (cephalexin CV vs co-amoxiclav)
	Baseline (n = 174)	Follow-up visit 1 (n = 174)	p-Value (baseline to follow-up 1)	Baseline (n = 87)	Follow-up visit 1 (n = 87)	p-Value (baseline to follow-up 1)	Baseline (n = 94)	Follow-up visit 1 (n = 94)	p-Value (baseline to follow-up 1)
Abscess; n (%)
Yes	69 (100.0)		<0.001	58 (100.0)		<0.001	8 (100.0)		<0.001	0.763	1.000
Improved		64 (92.8)			52 (89.7)			8 (100.0)
No change		5 (7.3)			6 (10.3)			0 (0.0)
Pericoronitis; n (%)
Yes	27 (100.0)		<0.001	14 (100.0)		<0.001	15 (100.0)		<0.001	1.000	1.000
Improved		24 (88.9)			12 (85.7)			13 (86.7)
No change		3 (11.1)			2 (14.3)			2 (13.3)
Re-exploration; n (%)
Yes			NA			NA			NA	NA	NA
Improved
No change
Dry socket; n (%)
Yes	2 (100.0)		0.333			NA	2 (100.0)		1.000	1.000	1.000
Improved		2 (100.0)						1 (50.0)
No change		0 (0.0)						1 (50.0)
Trismus; n (%)
Yes	19 (100.0)		<0.001	15 (100.0)		<0.001	10 (100.0)		0.474	0.571	<0.001
Improved		18 (94.7)			13 (86.7)			2 (20.0)
No change		1 (5.3)			2 (13.3)			8 (80.0)
Others; n (%)
No	174 (100.0)	174 (100.0)	1.000	87 (100.0)	87 (100.0)	1.000	94 (100.0)	94 (100.0)	1.000	1.000	1.000
Yes	0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)		0 (0.0)	0 (0.0)

Co-amoxiclav amoxicillin–clavulanic acid, CV clavulanic acid, n number of patients, N total patients, NA not applicable